Tuesday July 27, 2010 – Based on its recent research on the digital radiography market, Frost & Sullivan presents RF Co., Ltd. with the “2010 European Medical Technologies Product Leadership of the Year Award,” for NAOMI, a digital x-ray sensor that does not require any film development to acquire x-ray film images. The award banquet will be held on October 7, 2010 in Brussels, Belgium.
Frost & Sullivan, the Growth Partnership Company, with its head office in San Antonio, Texas, USA, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 40 offices on six continents.
Each year, Frost & Sullivan presents this award to a company that has developed high-quality products that offer innovative features/functionalities that enhance customer value and find immediate acceptance in the market.
There are 18 categories of awards in each market sector. This industry accolade is unique in that they are awarded by a company dedicated to the analysis and forecasting of high-tech markets since its inception in 1961. Frost & Sullivan analysts conduct a rigorous selection methodology unmatched by any other firm.
Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Over 1800 industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.
The awards is bestowed upon NAOMI for its significance of research in the healthcare industry in developing a unique CCD image processing technology that can produce satisfying high quality of digital images.
The following criteria were used and scored with 10-points evaluation to benchmark NAOMI performance against key competitors: (1)Product Features/Functionalities, (2)Innovative element of the Products, (3)Products’ Acceptance in the Marketplace, (4)Provides Customer Value Enhancements, and (5)Product Quality.
We believe that the award is the result of which our concept toward medical device development was highly appreciated and evaluated as well as NAOMI's distinguished technologies.
"The company believes that medical equipment should be physically friendly to patients, lessening the burden on doctors and medical staff and be affordable to even small clinics in depopulated areas," notes Frost & Sullivan Senior Research Analyst Sreevidhya Praveen.
Frost & Sullivan believes this vision will popularize NAOMI all over the world and it will be the ‘de facto standard’ in the field of digital direct radiography.
NAOMI uses sophisticated technology to emerge a patient- and environment-friendly medical equipment that is priced as lows as 30 per cent of that of its contemporaries, has ultra-sensitive high-resolution of 48.37 mega pixels (eight times more than its competing products) and low-level x-ray irradiance which is about 1/16 to 1/20 of conventional x-ray irradiance levels.
The impact of this technology on radiology is similar to the introduction of digital cameras in the videography market.